Apple Inc.

Microsoft Corporation

Meta Platforms, Inc.

Amazon.com, Inc.

Alphabet Inc.

NVIDIA Corporation

Amid bigtechs increasing capital expenditures on AI, Amazon, Google and Microsoft could collectively lose $900 billion in market capitalization since the release of their quarterly reports

"Staggering" $660 billion in AI spending by bigtechs has heightened market anxiety about a bubble

Pfizer Inc.

Sanofi

AgomAb Therapeutics N.V. American Depositary Shares

Agomab's Crohn's disease therapy is already being clinically tested

Agomab Therapeutics IPO: Pfizer and Sanofi-backed biotech starts trading

Once Upon A Farm Pbc

The company is listed on the NYSE under the ticker OFRM

Once Upon a Farm IPO: Shares of Jennifer Garner-cofounded company start trading 

SpyGlass Pharma, Inc. Common Stock

Preliminary trading in shares of SpyGlass Pharma has begun on the Freedom customer trading system. This biotech startup is developing a system designed to reduce intraocular pressure in patients with glaucoma and cataracts. Later on February 6, the company's securities will appear on the Nasdaq exchange under the ticker <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a>. Click on the <a href="https://tradernet.global/terminal?ticker=SGP.US">SGP</a> ticker to participate.

SpyGlass Pharma IPO: developer of eye disease therapy device goes public

Janux Therapeutics, Inc.

Legend Biotech Corporation

4D Molecular Therapeutics, Inc.

Arcturus Therapeutics Holdings Inc.

Altimmune, Inc.

Black Diamond Therapeutics, Inc.

The global biotechnology market was valued at about $1.65 trillion in 2025 and is projected to grow to $5.22 trillion by 2034 at a compound annual growth rate of 13.67%, according to <a href="https://straitsresearch.com/report/biotechnology-market">Straits Research</a>. The U.S. market remains the largest globally: it was worth $552.39 billion in 2023 and is expected to reach $1.24 trillion by 2030. Insider Monkey has <a href="https://www.insidermonkey.com/blog/20-best-biotech-stocks-under-20-to-buy-now-1685703/">selected</a>&nbsp;20 biotech companies trading below $20 per share that are widely held by hedge funds.

Insider Monkey names 20 under-$20 biotech stocks popular with hedge funds

On the night of Feb. 6, the value of bitcoin briefly approached $60,000 for the first time since October 2024

The crypto market is in a "phase of despair". Why does one strategist believe bitcoin will fall to zero?

Snowflake Inc.

Salesforce, Inc.

The scale of the selloff in software vendor stocks is perplexing to one of Wall Street's top "technobulls"

Wall Street's chief techno-optimist names 5 stocks to buy in the "soft-apocalypse"

Roblox Corporation

The Boeing Company

Oil stabilized amid expectations of US-Iran talks, which reduced geopolitical risks and weakened the price premium. Bitcoin hit a 16-month low amid a sell-off in technology stocks and investors' risk aversion. These and other topics - in our review of key events for the morning of February 6.

The main thing for the morning: oil stabilized, bitcoin updated the minimum for 16 months

Strategy Inc

Strategy, the largest corporate bitcoin holder, posted a quarterly loss of $12.4 billion

Bitcoin rebounded from the $60,000 level after collapsing 50% from its October peak

Novo Nordisk A/S

Eli Lilly and Company

Hims & Hers Health, Inc.

Shares of Novo Nordisk and Eli Lilly, makers of popular weight-loss drugs, fell in price after Hims &amp; Hers, which owns a telemedicine platform,<a href="https://investors.hims.com/news/news-details/2026/Hims--Hers-Expands-Personalized-Weight-Loss-Portfolio-with-Access-to-Compounded-Semaglutide-Pills-Starting-at-49Month/default.aspx"> announced</a> the launch of its own copy of the Wegovy slimming pill. And it will cost just $49 - three times cheaper than Novo's original, which investors <a href="https://oninvest.com/article/novo-vpecatlil-investorov-zapustiv-v-ssa-tabletku-dla-pohudenia-cto-u-konkurentov">had </a>high hopes for.

Novo Nordisk and Eli Lilly shares plummet: the weight-loss pill will have a $49 copy

Investors continued to exit risk assets on Thursday, February 5. This led to capital outflow from technology stocks and cryptocurrencies. Additional pressure on the market was exerted by macro data: unemployment in the U.S. was higher than expected. The S&amp;P 500 fell below the values of early January for the first time this year, CNBC <a href="https://www.cnbc.com/2026/02/04/stock-market-today-live-updates.html">noted</a>. And the Nasdaq 100 experienced the worst three-day decline since April, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-02-04/asian-stocks-to-fall-as-tech-led-drop-gains-pace-markets-wrap">writes</a>.

Nasdaq suffered its strongest three-day collapse since April, bitcoin fell in price to $63,000

The competition to expand AI infrastructure could fail all the tech companies involved, warns analyst DA Davidson

Donald Trump